cola lipid c efficacy against albicans Candida accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signaling Frontiers | Inhibitory Effects of
Frontiers Inhibitory Effects of Lipopeptides and Glycolipids on C. albicansStaphylococcus spp. Dual Species Biofilms The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo Scientific Reports Frontiers Pore forming peptide C14R exhibits potent antifungal activity against clinical isolates of Candida albicans and Candida auris Antifungal Efficacy of Antimicrobial Peptide Octominin II against Candida albicans
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



